Osaic Holdings
KPTI icon

Osaic Holdings’s Karyopharm Therapeutics KPTI Stock Holding History

Osaic Holdings’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24K Buy
402
+120
+43% +$915 ﹤0.01% 7009
2025
Q4 		$2.08K Sell
282
-64
-18% -$391 ﹤0.01% 7083
2025
Q3 		$2.41K Hold
346
– – ﹤0.01% 7083
2025
Q2 		$1.49K Hold
346
– – ﹤0.01% 7039
2025
Q1 		$1.29K Sell
346
-13
-4% -$111 ﹤0.01% 6742
2024
Q4 		$3.66K Buy
359
+66
+23% +$798 ﹤0.01% 6353
2024
Q3 		$3.64K Sell
293
-188
-39% -$2.34K ﹤0.01% 6359
2024
Q2 		$6.27K Sell
481
-92
-16% -$1.52K ﹤0.01% 6060
2024
Q1 		$13K Buy
573
+143
+33% +$2.51K ﹤0.01% 5611
2023
Q4 		$5.57K Sell
430
-33
-7% -$445 ﹤0.01% 6128
2023
Q3 		$9.3K Sell
463
-9
-2% -$202 ﹤0.01% 5947
2023
Q2 		$12.5K Sell
472
-122
-21% -$5.25K ﹤0.01% 5850
2023
Q1 		$34.6K Hold
594
– – ﹤0.01% 5210
2022
Q4 		$30K Buy
594
+341
+135% +$23.6K ﹤0.01% 5289
2022
Q3 		$21K Buy
253
+10
+4% +$747 ﹤0.01% 5546
2022
Q2 		$16K Hold
243
– – ﹤0.01% 5764
2022
Q1 		$27K Sell
243
-99
-29% -$12.3K ﹤0.01% 5491
2021
Q4 		$33K Sell
342
-1,074
-76% -$107K ﹤0.01% 5445
2021
Q3 		$124K Buy
1,416
+569
+67% +$59.1K ﹤0.01% 4333
2021
Q2 		$131K Sell
847
-36
-4% -$5.22K ﹤0.01% 4243
2021
Q1 		$139K Sell
883
-662
-43% -$139K ﹤0.01% 4082
2020
Q4 		$359K Sell
1,545
-6
-0.4% -$1.39K ﹤0.01% 2947
2020
Q3 		$340K Sell
1,551
-127
-8% -$31.1K ﹤0.01% 2778
2020
Q2 		$477K Buy
1,678
+520
+45% +$154K ﹤0.01% 2386
2020
Q1 		$333K Buy
+1,158
New +$319K ﹤0.01% 2434

Other funds holding KPTI

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Osaic Holdings's KPTI Position: Q1 2026 in Review

Osaic Holdings increased its Karyopharm Therapeutics (KPTI) stake by 43% in Q1 2026, buying an estimated $915 and bringing the position to 402 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #7009.

Osaic Holdings first reported a position in KPTI in Q1 2020 and has held it in 25 quarters since. The position peaked at $477K in Q2 2020. 77 funds tracked by Wall St. Rank hold KPTI as of Q1 2026.

  • Osaic Holdings held 402 shares of Karyopharm Therapeutics worth $2.24K as of Q1 2026.
  • Osaic Holdings bought 120 Karyopharm Therapeutics shares in Q1 2026, an estimated $915.
  • Karyopharm Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7009 holding.
  • Osaic Holdings first reported a position in Karyopharm Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Karyopharm Therapeutics position peaked at $477K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.